Meningococcal disease: guidance on public health management
Advice for health protection professionals on the management of meningococcal disease in the UK.
- From:
- UK Health Security Agency
- Published
- 1 March 2012
- Last updated
-
1223NovemberDecember20242025 — See all updates
Documents
Guidance for public health management of meningococcal disease
Ref: GOV-17581
PDF, 600926 KB, 6063 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
GP template chemoprophalaxischemoprophylaxis letter
Ref: GOV-17178
MS Word Document, 19.2 KB
This file may not be suitable for users of assistive technology.
Request an accessible format.
Examples of drug information leaflets
Ref: GOV-17178
MS Word Document, 17 KB
This file may not be suitable for users of assistive technology.
Request an accessible format.
Template GP vaccination letter for close contacts of MenA, C, W or Y disease
Ref: GOV-17178
MS Word Document, 15.8 KB
This file may not be suitable for users of assistive technology.
Request an accessible format.
Template letter for GP following a local case of IMD at nursery, school or university
Ref: GOV-17178
MS Word Document, 16.6 KB
This file may not be suitable for users of assistive technology.
Request an accessible format.
Communication with GP for immunological work-up of a case
Ref: GOV-17178
MS Word Document, 16.1 KB
This file may not be suitable for users of assistive technology.
Request an accessible format.
Communication with parents following a nursery case of IMD
Ref: GOV-17178
MS Word Document, 22.6 KB
This file may not be suitable for users of assistive technology.
Request an accessible format.
Communication with parents following a school case of IMD
Ref: GOV-17178
MS Word Document, 22.9 KB
This file may not be suitable for users of assistive technology.
Request an accessible format.
Communication with students following a university case of IMD
Ref: GOV-17178
MS Word Document, 22.4 KB
This file may not be suitable for users of assistive technology.
Request an accessible format.
Details
Management, guidance and control measures from UK Health Security Agency’s Vaccine Preventable Invasive Bacterial Infections Forum.
This guidance on the public health management of individual cases and clusters of invasive meningococcal disease (IMD) includes information on:
- epidemiology of IMD
- vaccination programmes
- laboratory investigations of suspected cases
- public health actions after a case
- chemoprophylaxis in healthcare settings
- clusters and management
Details
Management, guidance and control measures from UK Health Security Agency’s Vaccine Preventable Invasive Bacterial Infections Forum.
This guidance on the public health management of individual cases and clusters of invasive meningococcal disease (IMD) includes information on:
- epidemiology of IMD
- vaccination programmes
- laboratory investigations of suspected cases
- public health actions after a case
- chemoprophylaxis in healthcare settings
- clusters and management
Updates to this page
Sign up for emails or print this page
Update history
2025-12-23 12:00
Updated guidance – see change history.
2024-11-12 09:21
Updated guidance – see change history.
2024-10-08 13:31
Updated guidance – see change history.
2024-09-17 09:30
Updated guidance and letter templates.